Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial

BACKGROUND: Despite the reported health effects of cardamom on dyslipidemia, hepatomegaly, and fasting hyperglycemia, no human research has studied its potency in non-alcoholic fatty liver disease (NAFLD) as the hepatic part of metabolic syndrome. Our aim was determining the effects of green cardamo...

Descripción completa

Detalles Bibliográficos
Autores principales: Daneshi-Maskooni, Milad, Keshavarz, Seyed Ali, Qorbani, Mostafa, Mansouri, Siavash, Alavian, Seyed Moayed, Badri-Fariman, Mahtab, Jazayeri-Tehrani, Seyed Ali, Sotoudeh, Gity
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419418/
https://www.ncbi.nlm.nih.gov/pubmed/30871514
http://dx.doi.org/10.1186/s12906-019-2465-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419418/
https://www.ncbi.nlm.nih.gov/pubmed/30871514
http://dx.doi.org/10.1186/s12906-019-2465-0

Ejemplares similares